Psychedelic-Assisted Psychotherapy
Cambridge University Press eBooks May 28, 2021 DOI: 10.1017/9781108686976.030 via OpenAlex
Summary
AI-generated from the abstractClinical research suggests significant efficacy for psychiatric disorders that have traditionally been hard to treat, with psychedelic-assisted psychotherapy moving from a fringe subject to a significant new treatment method that all psychotherapists should be aware of and some may develop into a special interest.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Interventions | MDMA psilocybin LSD |
| Topics | Psilocybin |
| Keywords | Psychotherapist Psychology Subject documents Psychiatry |
| Citations | 2 |
| Key finding | Psychedelic-assisted psychotherapy appears to be moving from a fringe subject to a significant new treatment method for psychiatric disorders that have traditionally been hard to treat. |
Abstract
In recent years there has been a resumption of research into the potential therapeutic benefits of psychedelic1 drugs such as MDMA2, psilocybin and LSD3. Clinical research suggests significant efficacy for psychiatric disorders that have traditionally been hard to treat. The evidence base has accumulated to the point that psychedelic-assisted psychotherapy appears to be moving from a fringe subject to a significant new treatment method that all psychotherapists should at least be aware of and that some may develop into a special interest.